how long should you be on glp-1 Can Take a Drug Less Often if You're at Your Goal Weight? GLP-1 Treatment Duration: Clinical Evidence

In small proof-of-concept phase 2 randomized controlled trials (RCTs) in patients with biopsy-confirmed MASH, liraglutide at 1.8 mg/day for 48 weeks (201), semaglutide at 0.4 mg/day for 72 weeks (202), and tirzepatide at 15 mg/week for 52 weeks (203) have been reported to achieve placebo-corrected percentages of participants meeting the criteria for resolution of MASH without worsening fibrosis by 30% (P = 0.019), 42% (P 10%) may lead to diabetes remission (237)

These actions help regulate blood sugar levels after eating, making GLP-1 receptor agonists an effective treatment for diabetes

Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet

M.ChenW